Lidocaine Injection Generics bulk supplier for pharma manufacturers

Lidocaine Injection Generics Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 0.5% (5 mg/mL), 1% (10 mg/mL), 2% (20 mg/mL)

Reference Brands: Xylocaine®, Lidocaine Injection USP(US & EU)

Category: Anaesthetics

Lidocaine Injection Generics is available in Injection and strengths such as 0.5% (5 mg/mL), 1% (10 mg/mL), 2% (20 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lidocaine Injection Generics is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Lidocaine Injection Generics can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Lidocaine Injection is a fast-acting local anesthetic and Class 1B antiarrhythmic widely used in surgical, dental, and emergency care settings. Available in 0.5%, 1%, and 2% strengths, with or without epinephrine, it provides effective pain control for infiltration, nerve blocks, epidurals, and IV use. Lidocaine Injection is FDA-approved in the US and CE-marked in the EU, making it a trusted solution in hospitals and clinics. Offered in preservative-free and multi-dose formats, it meets varied clinical needs. This high-demand injectable presents excellent B2B opportunities for distributors, hospitals, tenders, and licensing partners in regulated pharmaceutical markets.

Frequently Asked Questions

Yes, Lidocaine Injection Generics is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Lidocaine Injection Generics is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Tetracaine Hcl And Generics

Strength: 1%

Form: injection

Reference Brands:

View Details
Tetracaine Hcl And Generics

Strength: 1%

Form: injection

Reference Brands:

View Details
Procaine Generics

Strength: 0.5%, 1%, 2% and 10%

Form: Injection

Reference Brands: Novocain, Procainum(EU & US)

View Details
Articaine

Strength: 4% Articaine + Epinephrine 1:100,000 or 1:200,000

Form: Injectable (cartridge/vial)

Reference Brands: Septanest®(EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.